Skip to main content
Year archive

NEUROTECH INTERNATIONAL LIMITED — 2021 filings

All 78 regulatory filings released by NEUROTECH INTERNATIONAL LIMITED (NTI) in 2021, sourced directly from the official regulator.

78 Filings
2021 Period
2021 filings (78)
Filing Released Lang
Notification regarding unquoted securities - NTI 5 pages 26.5KB
Share Issue/Capital Change
2021-12-12 English
Notification regarding unquoted securities - NTI 5 pages 26.6KB
Share Issue/Capital Change
2021-12-12 English
Change of Director's Interest Notice x 2 4 pages 319.5KB
Director's Dealing
2021-12-12 English
Preclinical Success with Targeted Combination Therapies 5 pages 311.6KB
Regulatory Filings
2021-11-30 English
Results of Meeting 3 pages 163.0KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-17 English
Application for quotation of securities - NTI 6 pages 27.8KB
Share Issue/Capital Change
2021-11-15 English
Change of Director's Interest Notice 2 pages 880.0KB
Director's Dealing
2021-11-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 1.6MB
Interim / Quarterly Report
2021-10-28 English
NTI to Present at the South-West Connect ASX Showcase 1
Investor Presentation
2021-10-24 English
Investor Presentation 15 pages 834.2KB
Investor Presentation
2021-10-24 English
Successful Completion of Preclinical MS Studies 4 pages 256.0KB
Regulatory Filings
2021-10-21 English
Notice of Annual General Meeting/Proxy Form 32 pages 1.0MB
AGM Information
2021-10-18 English
Annual Report (Typeset) 88 pages 2.7MB
Annual Report
2021-10-18 English
Provisional Patent Lodgements 2 pages 129.6KB
Regulatory Filings
2021-10-13 English
Response to ASX Query Letter 6 pages 302.5KB
Regulatory Filings
2021-10-13 English
Trading Halt 2 pages 139.9KB
Regulatory Filings
2021-10-11 English
ASX Listing Rule 3.13.1 Notice Regarding AGM 1 page
AGM Information
2021-09-28 English
NTI164 Clinical Program Update 2 pages 157.0KB
Regulatory Filings
2021-09-22 English
IRD Invest Conference - Webinar Presentation 1 page
Investor Presentation
2021-09-20 English
Ceasing to be a substantial holder 2 pages 227.0KB
Regulatory Filings
2021-09-13 English
Appendix 4E and Annual Report 75 pages 1.1MB
Annual Report
2021-08-29 English
Appendix 4G and Corporate Governance Statement 27 pages 414.4KB
Governance Information
2021-08-29 English
Investor Presentation 15 pages 1.1MB
Investor Presentation
2021-08-04 English
Investor Webinar Presentation 1 page 79.5KB
Investor Presentation
2021-08-04 English
Quarterly Report and Appendix 4C 10 pages 378.0KB
Interim / Quarterly Report
2021-07-29 English
Phase I/II Clinical Trial Update 3 pages 360.1KB
Regulatory Filings
2021-07-20 English
Change of Director's Interest Notice 2 pages 150.9KB
Director's Dealing
2021-07-19 English
Change of Director's Interest Notice 2 pages 169.5KB
Director's Dealing
2021-07-14 English
Further Success with Preclinical Testing Program - MS Models 2 pages 144.9KB
Regulatory Filings
2021-07-06 English
Appendix 3G 18 pages 247.2KB
Capital/Financing Update
2021-06-30 English
Update - Proposed issue of securities - NTI 6 pages 30.7KB
Capital/Financing Update
2021-06-28 English
Change of Director's Interest Notice 3 pages 155.8KB
Director's Dealing
2021-06-22 English
NTI to Present at the Gold Coast Investment Showcase 1
Investor Presentation
2021-06-22 English
Investor Presentation 18 pages 1.3MB
Investor Presentation
2021-06-15 English
NTI Strains Demonstrate Potential Benefits for MS Management 3 pages 125.4KB
Regulatory Filings
2021-05-24 English
Appointment of Allan Cripps as Non-Executive Director 2 pages 76.9KB
Board/Management Information
2021-05-19 English
Initial Director's Interest Notice 2 pages 134.9KB
Director's Dealing
2021-05-19 English
Proposed issue of Securities - NTI 5 pages 27.9KB
Capital/Financing Update
2021-05-19 English
Appendix 2A 15 pages 222.9KB
Capital/Financing Update
2021-05-18 English
Update - Proposed issue of Securities - NTI 6 pages 30.4KB
Regulatory Filings
2021-05-11 English
Update - Proposed issue of Securities - NTI 6 pages 30.5KB
Capital/Financing Update
2021-05-11 English
Appendix 2A 15 pages 218.7KB
Regulatory Filings
2021-05-11 English
Results of Meeting 2 pages 130.2KB
Declaration of Voting Results & Voting Rights Announcements
2021-05-06 English
Neurotech initiates Phase I/II Open Label Study into Autism 2 pages 97.1KB
Regulatory Filings
2021-05-04 English
Quarterly Report and Appendix 4C 9 pages 307.1KB
Interim / Quarterly Report
2021-05-02 English
Update - Proposed issue of Securities - NTI 6 pages 30.3KB
Capital/Financing Update
2021-04-22 English
Disclosure Document 41 pages 471.2KB
Capital/Financing Update
2021-04-18 English
Proposed issue of Securities - NTI 6 pages 30.3KB
Capital/Financing Update
2021-04-18 English
Appendix 2A 15 pages 221.1KB
Regulatory Filings
2021-04-15 English
Change of Director's Interest Notice 2 pages 135.7KB
Director's Dealing
2021-04-14 English
Initial Director's Interest Notice 2 pages 130.9KB
Director's Dealing
2021-04-11 English
Notice of General Meeting/Proxy Form 35 pages 937.2KB
Proxy Solicitation & Information Statement
2021-04-06 English
Appointment of Krista Bates as Non-Executive Director 2 pages 77.6KB
Board/Management Information
2021-04-05 English
Proposed issue of Securities - NTI 6 pages 30.3KB
Capital/Financing Update
2021-04-05 English
Appendix 2A 15 pages 222.7KB
Regulatory Filings
2021-03-31 English
Human Clinical Trial Update 2 pages 98.8KB
Regulatory Filings
2021-03-30 English
Appendix 2A 15 pages 222.8KB
Regulatory Filings
2021-03-25 English
Appendix 2A 15 pages 222.9KB
Capital/Financing Update
2021-03-18 English
Disclosure Document 36 pages 418.5KB
Capital/Financing Update
2021-03-14 English
Proposed issue of Securities - NTI 6 pages 30.4KB
Capital/Financing Update
2021-03-14 English
Appendix 2A 16 pages 226.5KB
Regulatory Filings
2021-03-14 English
Strategic Cultivation Partnership with CannaPacific 2 pages 112.4KB
Capital/Financing Update
2021-03-08 English
Proposed issue of Securities - NTI 6 pages 29.6KB
Capital/Financing Update
2021-03-08 English
Appendix 2A 15 pages 218.9KB
Share Issue/Capital Change
2021-03-03 English
Notice of Expiry of Listed Options 3 pages 120.1KB
Capital/Financing Update
2021-03-03 English
Neurotech Secures $3.56m in Funding 5 pages 161.9KB
Capital/Financing Update
2021-03-01 English
Neurotech Expands License with Dolce Cann Global 2 pages 83.5KB
Capital/Financing Update
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 28.0KB
Capital/Financing Update
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 28.3KB
Capital/Financing Update
2021-03-01 English
Proposed issue of Securities - NTI 6 pages 29.8KB
Share Issue/Capital Change
2021-03-01 English
Proposed issue of Securities - NTI 6 pages 29.8KB
Capital/Financing Update
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 27.4KB
Capital/Financing Update
2021-03-01 English
Proposed issue of Securities - NTI 5 pages 27.5KB
Capital/Financing Update
2021-03-01 English
Trading Halt 2 pages 179.3KB
Capital/Financing Update
2021-02-25 English
Appendix 4D and Half Year Accounts 23 pages 683.2KB
Interim / Quarterly Report
2021-02-25 English
Phase One and Two Clinical Program Update 2 pages 123.2KB
Regulatory Filings
2021-02-14 English
Quarterly Report and Appendix 4C 9 pages 304.8KB
Interim / Quarterly Report
2021-01-28 English
Q&A with NTI Company Chairman, Brian Leedman 4 pages 113.0KB
Investor Presentation
2021-01-19 English